Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe history list now includes a new entry: Revision: v3.3.3. The HHS Vulnerability Disclosure footer link was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the page history. This is a minor maintenance update that does not affect study data, eligibility, or results.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page no longer shows a government funding notice banner about operating status. This change does not affect trial data or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check67 days agoChange DetectedThe New Screenshot shows the same Version History layout with identical fields as the Old Screenshot; only minor styling differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference10%

- Check95 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.2%

Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.